Trinity Biotech stock. The diagnostics maker stays in view.

Trinity Biotech plc (US8942251025) is a diagnostics company with a US listing and a portfolio centered on point-of-care and laboratory testing. The shares trade on Nasdaq under TRIB, giving US investors a direct market reference point.

Business model

The company develops and markets diagnostic products across infectious disease, diabetes, and related testing categories. Its investor relations materials describe a business built around recurring demand for medical testing and clinical diagnostics.

Market setup

For US investors, the most useful anchor is the Nasdaq listing and the company's healthcare exposure. Trinity Biotech's positioning in diagnostics keeps the stock tied to reimbursement trends, testing volumes, and broader healthcare demand.

Product focus

One representative product line is its diabetes testing and diagnostics portfolio, which reflects the company's core emphasis on clinical testing tools. That mix helps frame the business beyond the ticker alone.

Stock context

Trinity Biotech shares trade on Nasdaq in USD. As of July 8, 2026, the market price was not included in the available company context.